Dr. Azad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Baylor College of MedicineResidency, Internal Medicine, 2001 - 2004- Baylor College of MedicineClass of 2001
Certifications & Licensure
PA State Medical License 2004 - 2024
MD State Medical License 2008 - 2024
VA State Medical License 2005 - 2024
NC State Medical License 2020 - 2022
DC State Medical License 2013 - 2016- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies Start of enrollment: 2009 Nov 01
- Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer Start of enrollment: 2011 Jan 01
- A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer.Liu, I., Gearhart, S., Ke, S., Hu, C., Chung, H., Efron, J., Gabre-Kidan, A., Najjar, P., Atallah, C., Safar, B., Christenson, E., Azad, N., Lee, V., Zaheer, A., Birkn...> ;Surgery Open Science. 2024 Mar 1
- A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.Lee, V., Parkinson, R., Zahurak, M., Cope, L., Verheul, H., Gootjes, E., Jones, P., Baylin, S., Rami, V., El Khoueiry, A., Cercek, A., Lenz, H., Iqbal, S., Ahuja, N., ...> ;International Journal of Cancer. 2024 May 15
- Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations.Wilbur, H., Soares, H., Azad, N.> ;Hepatology. 2024 Jan 24
- Join now to see all
Lectures
- What Is Working in Clinical Trial Recruitment? - Panel ModeratorASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- ENCORE 601: A phase 2 study of entinostat in combination with pembrolizumab in patients with microsatellite stable metastatic colorectal cancer.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
This Type of Cancer Is Rising Among Young People. Here Are the Signs to Watch ForMarch 1st, 2023- ECOG-ACRIN Opens a New NCI-MATCH Treatment Arm for dMMR and LAG-3-Positive Cancers as It Continues to Locate Patients with BRAF MutationsMarch 16th, 2022
- Durvalumab Modestly Improves Survival in Advanced Biliary Tract CancerFebruary 10th, 2022
- Join now to see all
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Interventional Radiology, American College of Radiology 2015 - Present
Other Languages
- Urdu, Hindi
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/nilofer-azad
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
